Variant report

Variant	esv3436015
Chromosome Location	chr14:21649212-21653610
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	RFX5	chr14:21653146-21653180	H1-hESC	embryonic stem cell:	n/a	n/a
2	STAT3	chr14:21650453-21650569	MCF10A-Er-Src	breast:	n/a	n/a

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:21649811..21651897-chr14:21658475..21660736,2	MCF-7	breast:
2	chr14:21650511..21651012-chr3:158378169..158378669,2	Hela-S3	cervix:
3	chr14:21651029..21652913-chr14:21654690..21656270,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HNRNPC-2	chr14:21652500-21653118	NONHSAT035662

No data

Variant related genes	Relation type
ENSG00000258906	TF binding region
GFPT2	miRNA target sites

Extended variants
information (count: 166 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:166 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs549381859	chr14:21650052-21650053	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs368138732	chr14:21650058-21650059	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs149247410	chr14:21650171-21650172	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs12589558	chr14:21650221-21650222	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs551851200	chr14:21650280-21650281	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs368670311	chr14:21650294-21650295	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs12880105	chr14:21650295-21650296	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs537626431	chr14:21650337-21650338	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs550924167	chr14:21650342-21650343	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs185639677	chr14:21650347-21650348	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs536591797	chr14:21650461-21650462	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs549270807	chr14:21650463-21650464	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs554940356	chr14:21650474-21650475	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs571661151	chr14:21650483-21650484	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs11276719	chr14:21650486-21650487	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs398056922	chr14:21650492-21650493	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs534328916	chr14:21650555-21650556	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs577747665	chr14:21650605-21650606	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs530315877	chr14:21650619-21650620	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs532305682	chr14:21650628-21650629	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs577685536	chr14:21650629-21650630	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs543579878	chr14:21650653-21650654	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs563371479	chr14:21650680-21650681	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs190055897	chr14:21650720-21650721	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs181748160	chr14:21650732-21650733	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs559686473	chr14:21650743-21650744	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528452625	chr14:21650795-21650796	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs185446884	chr14:21650816-21650817	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs188655474	chr14:21650840-21650841	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs530944630	chr14:21650849-21650850	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs551148565	chr14:21650873-21650874	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs116922405	chr14:21650898-21650899	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs144786881	chr14:21650930-21650931	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs181360977	chr14:21650931-21650932	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs185241664	chr14:21650974-21650975	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs566840024	chr14:21651007-21651008	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs548938791	chr14:21651024-21651025	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs189900047	chr14:21651026-21651027	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs73573896	chr14:21651102-21651103	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs118075856	chr14:21651117-21651118	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs536786016	chr14:21651122-21651123	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs557113200	chr14:21651129-21651130	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs372360104	chr14:21651162-21651163	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs573830883	chr14:21651170-21651171	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs28380206	chr14:21651171-21651172	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs182216940	chr14:21651187-21651188	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs148546106	chr14:21651228-21651229	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs202064432	chr14:21651245-21651246	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs9707698	chr14:21651253-21651254	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs35230291	chr14:21651258-21651259	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cone-rod dystrophy	18421352	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Alzheimer''s disease	21482944	CNVD
Mental retardation	19951919	CNVD
Neuroblastoma	21899760	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Heart disease	21282601	CNVD
Esophageal cancer	20955586	CNVD
Neurodevelopmental disorder	22521361	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17440070	CNVD
Breast cancer	16272173	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Epilepsy	20736978	CNVD
Mental retardation	20736978	CNVD
severe speech impairment	20736978	CNVD
speech impairment	20736978	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
Cancer	20164919	CNVD
Breast cancer	21364760	CNVD
Mortal	21835882	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	21858162	CNVD
Schizophrenia	20967226	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22102821	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Neuroblastoma	19536264	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:18 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:21650000-21651400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr14:21650800-21651000	Enhancers	Fetal Brain Male	brain
3	chr14:21650800-21651200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr14:21651000-21652000	Weak transcription	Fetal Brain Male	brain
5	chr14:21651200-21659600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
6	chr14:21651400-21651800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr14:21651800-21652800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr14:21652000-21654200	Enhancers	Fetal Brain Male	brain
9	chr14:21652800-21653000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr14:21652800-21653200	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr14:21653000-21653600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr14:21653000-21654200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr14:21653200-21654000	Enhancers	Small Intestine	intestine
14	chr14:21653200-21654200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr14:21653200-21654200	Enhancers	Fetal Lung	lung
16	chr14:21653200-21654800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr14:21653400-21654200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr14:21653600-21654200	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links